We don't. First cohort would start at a fraction of the animal MTD. First cohort dosing based fully on preclinical lab work. Privy info till human MTD established. Strong dose not first cohort goal - exploration of safety,tolerability and toxicity first cohort goals. Any positive effect is just huge bonus.